Dementia is a neurological disease that mainly affects the elderly. A recent finding shows that one everyday drink can help lower a person’s risk of developing the condition.
Although the exact cause of the disease has yet to be determined, Express reports that as early as now, people can make some lifestyle changes to lower their risk of developing the condition later on. The Institute for Scientific Information on Coffee reveals that drinking coffee can be beneficial in preventing neurodegenerative disorders that could happen in the later years. The team of researchers involved, led by Dr. Elisabet Rothenberg, analyzed previous studies on the links between dietary changes and neurological disorders such as Alzheimer’s and Parkinson’s.
According to their analysis, a higher intake of coffee will prevent the risk of developing the symptoms as well as alleviate the symptoms if already present. The suggested amount, Dr. Rothenberg says, is five cups of coffee a day can help protect the brain from neurodegenerative disorders in the future.
The association between caffeine and neurological disorders has yet to be defined, but this is still a step closer to further understanding of why it is. It will also further research into the benefits of coffee on a person.
On another note, the US National Library of Medicine National Institutes of Health also analyzed several studies regarding the caffeine found in coffee being associated with helping prevent dementia in the elderly. Out of five studies that were analyzed, three were found to support the effects of coffee on the nervous system. As tea also has caffeine content, two studies combined the effects of both coffee and tea on a person’s nervous system and found that the two drinks did help in cognitive functioning.
While there are already results linking the association between coffee and the prevention of dementia, there has yet to be results regarding tea having the same effect as coffee when protecting the brain against neurodegenerative diseases.
In one study, drinking three to five cups a day at midlife was linked to a decrease in developing dementia in the later years by 65 percent.


AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
FDA Approves Mitapivat for Anemia in Thalassemia Patients
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 



